Global Patent Index - EP 1060166 A1

EP 1060166 A1 2000-12-20 - FIVE-MEMBERED, BENZO-CONDENSED HETEROCYCLES USED AS ANTITHROMBOTIC AGENTS

Title (en)

FIVE-MEMBERED, BENZO-CONDENSED HETEROCYCLES USED AS ANTITHROMBOTIC AGENTS

Title (de)

5-GLIEDRIGE BENZOKONDENSIERTE HETEROCYCLEN ALS ANTITHROMBOTIKA

Title (fr)

HETEROCYCLES BENZO CONDENSES A 5 CHAINONS UTILISES COMME AGENTS ANTITHROMBOTIQUES

Publication

EP 1060166 A1 (DE)

Application

EP 99907437 A

Priority

  • DE 19804085 A
  • DE 19834325 A
  • EP 9900537 W

Abstract (en)

[origin: WO9940072A1] The invention relates to new five-membered, heterocyclic condensed benzoderivatives of the general formula (I), in which Ra to Rc, A, Ar, X and Y have the meanings assigned in claim 1, and their tautomers, stereoisomers, mixtures and salts, especially their physiologically compatible salts with inorganic or organic acids or bases, which have valuable properties. The compounds of the general formula (I) above, in which Rc is a cyano group, present valuable intermediate products for the production of the remaining compounds of the general formula (I), and the compounds of the above general formula (I), in which Rc is one of the following amidino groups, as well as their tautomers and stereoisomers, have valuable pharmacological properties, especially an antithrombotic activity.

IPC 1-7 (main, further and additional classification)

C07D 235/16; A61K 31/415; C07D 209/18; C07D 263/56; C07D 277/64; C07D 307/81; C07D 401/06; C07D 401/12; C07D 403/12; C07D 403/14; C07D 405/12; C07D 405/14; C07D 413/06; C07D 413/14; C07F 9/32

IPC 8 full level (invention and additional information)

C07D 277/66 (2006.01); A61K 31/403 (2006.01); A61K 31/404 (2006.01); A61K 31/415 (2006.01); A61K 31/4164 (2006.01); A61K 31/4184 (2006.01); A61K 31/423 (2006.01); A61K 31/428 (2006.01); A61K 31/4427 (2006.01); A61K 31/443 (2006.01); A61K 31/4439 (2006.01); A61K 31/454 (2006.01); A61K 31/4709 (2006.01); A61K 31/4725 (2006.01); A61K 31/496 (2006.01); A61K 31/502 (2006.01); A61K 31/5355 (2006.01); A61K 31/5377 (2006.01); A61P 7/02 (2006.01); A61P 9/10 (2006.01); C07D 209/14 (2006.01); C07D 209/24 (2006.01); C07D 235/16 (2006.01); C07D 263/56 (2006.01); C07D 277/28 (2006.01); C07D 277/64 (2006.01); C07D 307/81 (2006.01); C07D 401/04 (2006.01); C07D 401/06 (2006.01); C07D 401/08 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 403/04 (2006.01); C07D 403/06 (2006.01); C07D 403/08 (2006.01); C07D 403/12 (2006.01); C07D 403/14 (2006.01); C07D 405/12 (2006.01); C07D 405/14 (2006.01); C07D 417/12 (2006.01); C07F 9/32 (2006.01); C07F 9/6506 (2006.01)

CPC (invention and additional information)

C07D 263/56 (2013.01); C07D 209/24 (2013.01); C07D 235/16 (2013.01); C07D 277/64 (2013.01); C07D 401/06 (2013.01); C07D 401/08 (2013.01); C07D 401/12 (2013.01); C07D 403/04 (2013.01); C07D 403/08 (2013.01); C07D 403/12 (2013.01); C07D 405/12 (2013.01); C07D 417/12 (2013.01); C07F 9/65068 (2013.01)

Citation (search report)

See references of WO 9940072A1

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 9940072 A1 19990812; AU 2720199 A 19990823; CA 2319494 A1 19990812; EP 1060166 A1 20001220; JP 2002502844 A 20020129

INPADOC legal status


2007-10-17 [18D] DEEMED TO BE WITHDRAWN

- Effective date: 20070327

2007-01-10 [17Q] FIRST EXAMINATION REPORT

- Effective date: 20061117

2003-03-26 [RAP1] TRANSFER OF RIGHTS OF AN EP PUBLISHED APPLICATION

- Owner name: BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG

2000-12-20 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20000904

2000-12-20 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A1

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

2000-12-20 [AX] REQUEST FOR EXTENSION OF THE EUROPEAN PATENT TO

- Free text: LT PAYMENT 20000904;LV PAYMENT 20000904;RO PAYMENT 20000904;SI PAYMENT 20000904